Treatment Strategies for Hypertrophic Cardiomyopathy: Surgical.
Am J Cardiol
; 212S: S53-S63, 2024 02 01.
Article
en En
| MEDLINE
| ID: mdl-38368037
ABSTRACT
Septal myectomy is a well-established procedure for septal reduction in patients with obstructive hypertrophic cardiomyopathy (HCM) who have not responded to medical treatment. The surgical approach is tailored to the unique pathophysiology and septal morphology of the patient. Extended transaortic myectomy is the standard procedure for patients with isolated subaortic obstruction, the most common type of HCM. However, transapical myectomy is a useful adjunct for patients with long or midventricular obstruction and is our preferred technique for ventricular enlargement in patients with severe symptomatic diastolic heart failure because of extensive apical hypertrophy. Septal myectomy provides excellent postoperative outcomes as regards symptom relief and functional improvement, and operative morbidity and mortality rates are low in experienced centers. This article summarizes our current surgical management of patients with HCM and details operative methods and outcomes.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Cardiomiopatía Hipertrófica
/
Procedimientos Quirúrgicos Cardíacos
Límite:
Humans
Idioma:
En
Revista:
Am J Cardiol
Año:
2024
Tipo del documento:
Article